The Tisch Cancer Institute at Mount Sinai is a leader in translating clinical research into cancer immunotherapies for patients. PICI researcher Nina Bhardwaj, MD, PhD, at Mount Sinai is an expert who contributes foundational insights in understanding patient responses to immunotherapy treatments. She closely examines immune behavior to test and develop cancer-curing vaccines. Bhardwaj is instrumental on several PICI research projects and clinical trials, with a focus on prostate and pancreatic cancers. Nina Bhardwaj, MD, PhD | Investigator Related Research Focus Tumor Antigen Discovery: Targeting Cancer Research Project Tumor Neoantigen Selection Alliance (TESLA) Announcement, Our Impact, Research Update 5 Years of Transforming Cancer Immunotherapy Research Announcement, Our Impact, Research Update New CAR-T Approach Shows Promise for Lymphoma Patients Press Release Funding the Future of Cancer Research Cancer Research Heroes Improving Conventional Wisdom: From CAR-T Therapy to Diversity in STEM, Avery Posey Has Big Ideas Press Release Ute Dugan Joins PICI as Senior VP of Clinical Research Partner Highlight Seeking Solutions for Deadly Brain Tumors: ACGT Our Impact, Research Update Tackling Pancreatic Cancer with a Triple Threat
Cancer Research Heroes Improving Conventional Wisdom: From CAR-T Therapy to Diversity in STEM, Avery Posey Has Big Ideas